U.S. MarketsOctober 2 at 03:08 PM

Eli Lilly (LLY) announced that the US FDA has approved an additional indication for Jaypirca

StockNow breaking-news AI analysis

Eli Lilly announced FDA approval of an additional Jaypirca indication; the supplied report does not specify which indication or provide further approval details.

1 stocks

LLYEli Lilly & Co.$1,142.86Current price

What do investors think?

Curious what other investors think?Log in to see reactions and join the conversation.

StockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.

Today's market highlights

A selection of stories drawing attention in the market.

Commodities

US President Trump posts "Europe has just agreed to release a massive amount of their heavily stocked Diesel Oil. The process will begin immediately. Thank you for your attention to this matter! President DJT"

Geopolitics

"Yemen's retaliatory attacks on Saudi Arabia; Explosions heard in Riyadh", reports SNN